Impact of Drug Abuse Treatment Modalities on Adherence to ART/HAART Among a Cohort of HIV Seropositive Women

REFERENCES

• Wood E, Montaner J S, Yip B, Tyndall M W, Schechter M T, O'Shaughnessy M V, Hogg R S. Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ 2003; 169: 656–661
   PubMed Web of Science ®Google Scholar
• Arnsten J H, Demas P A, Grant R W, Gourevitch M N, Farzadegan H, Howard A A, Schoenbaum E E. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 2002; 17: 377–381
   PubMed Web of Science ®Google Scholar
• Wilson T E, Barron Y, Cohen M, Richardson J, Greenblatt R, Sacks H S, Young M. Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis 2002; 34: 529–534
   PubMed Web of Science ®Google Scholar
• Lucas G M, Cheever L W, Chaisson R E, Moore R D. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr 2001; 27: 251–259
   PubMed Web of Science ®Google Scholar
• Stein M D, Rich J D, Maksad J, Chen M H, Hu P, Sobota M, Clarke J. Adherence to antiretroviral therapy among HIV-infected methadone patients: Effect of ongoing illicit drug use. Am J Drug Alcohol Abuse 2000; 26: 195–205
   PubMed Web of Science ®Google Scholar
• Moatti J P, Carrieri M P, Spire B, Gastaut J A, Cassuto J P, Moreau J. Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 study group. AIDS. 2000; 14: 151–155
   PubMed Web of Science ®Google Scholar
• Avants S K, Margolin A, Warburton L A, Hawkins K A, Shi J. Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. Am J Addict 2001; 10: 69–78
   PubMed Web of Science ®Google Scholar
• Palepu A, Tyndall M W, Joy R, Kerr T, Wood E, Press N, Hogg R S, Montaner J S. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy. Drug Alcohol Depend 2006; 84: 188–194
   PubMed Web of Science ®Google Scholar
• Cumberbatch Z, Copersino M, Stitzer M, Jones H. Comparative drug use and psychosocial profiles of opioid dependents applying for medication versus medication-free treatment. Am J Drug Alcohol Abuse 2004; 30: 237–249
   PubMed Web of Science ®Google Scholar
• Greenfield S F, Brooks A J, Gordon S M, Green C A, Kropp F, McHugh R K, Lincoln M, Hien D, Miele G M. Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug Alcohol Depend 2006
   Google Scholar
• Ashley O S, Marsden M E, Brady T M. Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse 2003; 29: 19–53
   PubMed Web of Science ®Google Scholar
• Barkan S E, Melnick S L, Preston-Martin S, Weber K, Kalish L A, Miotti P, Young M, Greenblatt R, Sacks H, Feldman J. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998; 9: 117–125
   PubMed Web of Science ®Google Scholar
• DHHS and Henry J. Kaiser Family Foundation. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, February 2001 revision
   Google Scholar
• Paterson D L, Swindells S, Mohr J, Brester M, Vergis E N, Squier C, Wagener M M, Singh N. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000; 133: 21–30
   PubMed Web of Science ®Google Scholar
• Radloff L S. The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 385: 1, US
   Google Scholar
• Weissman M M, Sholomskas D, Pottenger M, Prusoff B A, Locke B Z. Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977; 106: 203–214
   PubMed Web of Science ®Google Scholar
• Hardin J W. Generalized Estimating Equations. Chapman & Hall/CRC Press, Boca Raton 2002
   Google Scholar
• Zeger S L, Liang K Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121–130
   PubMed Web of Science ®Google Scholar
• Brown L S, Jr., Kritz S A, Goldsmith R J, Bini E J, Rotrosen J, Baker S, Robinson J, McAuliffe P. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat 2006; 30: 315–321
   PubMed Web of Science ®Google Scholar
• Conway B, Prasad J, Reynolds R, Farley J, Jones M, Jutha S, Smith N, Mead A, DeVlaming S. Directly observed therapy for the management of HIV-infected patients in a methadone program. Clin Infect Dis 2004; 38: S402–S408, Suppl 5
   PubMed Web of Science ®Google Scholar
• Lucas G M, Weidle P J, Hader S, Moore R D. Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study. Clin Infect Dis 2004; 38: S409–S413, Suppl 5
   PubMed Web of Science ®Google Scholar
• Berg K M, Demas P A, Howard A A, Schoenbaum E E, Gourevitch M N, Arnsten J H. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med 2004; 19: 1111–1117
   PubMed Web of Science ®Google Scholar
• Sharpe T T, Lee L M, Nakashima A K, Elam-Evans L D, Fleming P L. Crack cocaine use and adherence to antiretroviral treatment among HIV-infected black women. J Community Health 2004; 29: 117–127
   PubMed Web of Science ®Google Scholar